Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA 330-II Hemofiltration in Acute Liver Failure
NCT04243655Phase 4Unknown
- Sponsor
- Asian Institute of Gastroenterology
- Start
- Dec 2019
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Asian Institute of Gastroenterology. Primary endpoint: Efficacy of HA 330-II to prolong liver-transplantation free survival at 30 days. Status: unknown.
Beyond the preview
Go deeper on NCT04243655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04243655.